Study: Pharmacists help reduce hospital admissions among those with dementia
By
Lois A. Bowers
Apr 05, 2016
If you’re seeking to reduce hospital admissions among those with dementia, involving a clinical pharmacist may help, according to new research from Sweden.
Fund Alzheimer’s research, Senate committee told
By
Lois A. Bowers
Apr 06, 2016
Witnesses testifying before the Senate Special Committee on Aging, and committee members themselves, called for more funding for Alzheimer’s research at an April 6 hearing.
Medicare spending spikes for dementia diagnoses in seniors
Jun 13, 2022
Medicare spending was higher for adults with a formal clinical diagnosis of dementia versus a positive screening for cognitive impairment.
Senior living braces for changes in 2020 as top challenges remain
By
Lois A. Bowers
Jan 02, 2020
As 2020 begins, the senior living industry is preparing for the changing needs and wants of current and future residents as workforce and occupancy issues continue to challenge operators, according to...
Medicare policy changes tied to drop in hospice use for dementia
May 09, 2022
Immediate and lasting reductions were seen in the share of patients receiving hospice care with the Alzheimer’s disease and related dementia code.
Alzheimer’s disease, related dementia diagnoses up in Medicare decedents
Apr 01, 2022
The percentage of older U.S. decedents with a diagnosis of Alzheimer’s disease and related dementias increased significantly from 2004 to 2017.
Pricey Alzheimer drug drives spike in Medicare B premium: Officials
Nov 15, 2021
New premium will be $170.10 a month, and the $21.60 boost is the biggest increase ever in dollar amount, but not in percentage terms
Biden pledges to lower prescription drug prices for Americans
Dec 07, 2021
But the biggest policy change — letting Medicare negotiate prices for prescription drugs — will not start to lower costs until 2025.
New Rx instructions tighten use of controversial Alzheimer’s disease drug
Jul 08, 2021
Major changes to prescribing instructions are rare, especially so soon after approval; it change could curb the drug’s use.
Biogen cuts price of controversial Aduhelm in half
Dec 21, 2021
The drug shows promise in clearing the brain plaques believed to play a role in Alzheimer’s disease.